MoneyWorks4Me

Everest Organics informs about listing approval

12 Mar 2025 Evaluate
Everest Organics has informed that the Company has received listing approval from BSE vide their letter bearing no: LOD/PREF/VK/FIP/1940/2024-25 dated March 11, 2025 for listing of 17,10,526 Equity shares of Rs 10 each issued to non-promoters on preferential basis. The approval letter received from BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..